{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:09:28Z","timestamp":1773018568561,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/md.0000000000010436","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T10:29:19Z","timestamp":1523442559000},"page":"e0436","source":"Crossref","is-referenced-by-count":41,"title":["Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis"],"prefix":"10.1097","volume":"97","author":[{"given":"Yushiro","family":"Endo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazusato","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-77-20210309","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R2-77-20210309","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R3-77-20210309","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R4-77-20210309","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"R5-77-20210309","first-page":"1719","article-title":"Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"J Rheumatol"},{"key":"R6-77-20210309","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/1756-185X.13136","article-title":"Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis","volume":"20","author":"Hisanaga","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R7-77-20210309","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-016-3443-2","article-title":"Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies","volume":"36","author":"Hayashi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R8-77-20210309","first-page":"9","article-title":"Recent treatment of interstitial lung disease with idiopathic inflammatory myopathies","volume":"9","author":"Kawasumi","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"R9-77-20210309","first-page":"189","article-title":"Short and longterm experience with plasmapheresis in connective tissue diseases","volume":"32","author":"Dequeker","year":"1980","journal-title":"Biomedicine"},{"key":"R10-77-20210309","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","article-title":"Clinically amyopathic dermatomyositis","volume":"22","author":"Sato","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R11-77-20210309","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology (Oxford"},{"key":"R12-77-20210309","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/ar3547","article-title":"Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan","volume":"13","author":"Muro","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R13-77-20210309","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"R14-77-20210309","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"},{"key":"R15-77-20210309","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford"},{"key":"R17-77-20210309","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2177\/jsci.36.71","article-title":"[Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia]","volume":"36","author":"Nakashima","year":"2013","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"R18-77-20210309","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"R19-77-20210309","doi-asserted-by":"crossref","first-page":"e3449","DOI":"10.1097\/MD.0000000000003449","article-title":"Multiple serum cytokine profiling to identify combinational diagnostic biomarkers in attacks of familial mediterranean fever","volume":"95","author":"Koga","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R20-77-20210309","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jca.21285","article-title":"Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis","volume":"28","author":"Bozkirli","year":"2013","journal-title":"J Clin Apher"},{"key":"R21-77-20210309","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/14397595.2013.852847","article-title":"Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases","volume":"24","author":"Ichiyasu","year":"2014","journal-title":"Mod Rheumatol"},{"key":"R22-77-20210309","first-page":"30","article-title":"Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody","volume":"49","author":"Nagata","year":"2011","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"R23-77-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2169\/internalmedicine.41.151","article-title":"Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis","volume":"41","author":"Sakamoto","year":"2002","journal-title":"Intern Med"},{"key":"R24-77-20210309","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/14397595.2013.844402","article-title":"Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis","volume":"25","author":"Kaieda","year":"2015","journal-title":"Mod Rheumatol"},{"key":"R25-77-20210309","first-page":"1838","article-title":"Clinical features of hemophagocytic syndrome in patients with dermatomyositis","volume":"35","author":"Yajima","year":"2008","journal-title":"J Rheumatol"},{"key":"R26-77-20210309","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/39.10.1157","article-title":"Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies","volume":"39","author":"Madaule","year":"2000","journal-title":"Rheumatology (Oxford"},{"key":"R27-77-20210309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000315922","article-title":"PMX endotoxin removal in the clinical practice: results from the EUPHAS trial","volume":"167","author":"Antonelli","year":"2010","journal-title":"Contrib Nephrol"},{"key":"R28-77-20210309","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1378\/chest.13-0186","article-title":"Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140\/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis","volume":"144","author":"Teruya","year":"2013","journal-title":"Chest"},{"key":"R29-77-20210309","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jca.21387","article-title":"Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease","volume":"30","author":"Omotoso","year":"2015","journal-title":"J Clin Apher"},{"key":"R30-77-20210309","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcv068","article-title":"Anti-MDA5 dermatomyositis and progressive interstitial pneumonia","volume":"109","author":"Silveira","year":"2016","journal-title":"QJM"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:04:09Z","timestamp":1620961449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201804130-00077"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010436","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}